Advances in the Study of Bacterial-mediated Antitumor Therapy

Jing Liu

doi:10.62051/ijphmr.v3n1.05

Authors

Jing Liu

DOI:

https://doi.org/10.62051/ijphmr.v3n1.05

Keywords:

Bacteriotherapy, Tumor therapy, Targeting, Anti-tumor

Abstract

Tumors, due to their complex pathophysiological properties and potential drug resistance, make it difficult for traditional treatment modalities, including radiotherapy, chemotherapy and immunotherapy, to completely eliminate tumor cells. As an emerging therapeutic strategy, bacteriotherapy demonstrates its unique advantages, which are highly targeted. Whether applied alone or in combination with nanotechnology, bacterial therapy can effectively prevent tumor recurrence and metastasis. With the help of genetic engineering technology, it is possible to enable bacteria to express anti-cancer drugs, and these bacteria are able to precisely target the tumor area and release therapeutic molecules to induce apoptosis of tumor cells. Bacteria-targeted therapy has great potential for development in the field of tumor therapy. The paper reviews the research progress of bacterial therapies, introduces the principle of various bacterial therapies for tumor treatment, the research progress of bacterial therapies combined with nanotechnology, and the limitations of this therapy.

References

[1] Wang, M., Su, W.Y. (2019). Bacteria: a new weapon against cancer. World Latest MedicineInformation.

[2] Liu, D., Mei, Q. B., Zhang, M. L.et al. (2023). Progress of bacterial targeted tumor therapy. Chinese Contemporary Medicine, 30 (08): 32-37.

[3] Liu, C.L., Dong, Y.X., Guo, X. (2021). Application of synthetic biology in promoting preclinical and clinical advances of bacterial anti-cancer therapy. Journal of Integration Technology, 10(04), 78-92.

[4] Shi, E. Y., Wang, N., Zhao, X. Y.et al. (2024). Advances in bacterial-mediated tumor therapy. Chinese Journal of Bioengineering, 44(2), 112-123.

[5] Chen, X., Zhang, W. J., Chen, Y. L.et al. (2024). Advances in Salmonella-mediated tumor therapy. Microbiology Bulletin (4).

[6] Lü, Z. R., Li, D. Y., Zhu, Y. Y.et al. (2024). Advances in Salmonella-mediated tumor-targeted therapy. Journal of Pharmacy, 59(1), 17-24.

[7] Li, Y. T., Cui, T. Q., Zhang H. L.et al.(2023). Progress of tumor-targeting bacterium escherichia coli nissle 1917 in cancer therapy. Chinese Journal of Bioengineering, 43(6), 54-68.

[8] Tan, Y. F. (2023). Heterologous expression study of the anticancer drug paclitaxel precursor paclitaxel diene in tumour-targeting bacteria. (Doctoral dissertation, Shandong University).

[9] Xue, X., Zhang, Y.Y., Wang, H.J. (2024). Progress of bacteria based on combined nanotechnology for tumour diagnosis and treatment. Chinese Journal of Biological Products, 37(1), 117-124.

[10] Li, Y. (2022). Anaerobic bacteria mediated 'smart missile' targeting tumor hypoxic area enhances the therapeutic outcome of lung cancer. Chemical Engineering Journal, 438, 135566-.

[11] Yao, M. (2023). Tumour microenvironment responsive functional materials for multimodal cancer therapy research. (Doctoral dissertation, Linyi University).

[12] Liang, Z.G. (2022). Bacteriophage-based biomimetic nanoparticles for tumour therapy (Master's thesis, University of Chinese Academy of Sciences (Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences)). M.S.

[13] Ren, H. Z., Yang, T. H., Wang, J. (2024). Bacteria-mediated synergistic therapeutic strategies for tumours. Chinese Journal of Tumour Biotherapy, 31(3), 296-302.

[14] Cui, C., Tu, Q., Zhang, Y. M. (2021). Research progress of bacteria for targeted therapy of tumours. Chinese Journal of Antibiotics, 46(5), 8.